Published guidance, NICE advice and quality standards | Guidance

Showing 551 to 560 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Ustekinumab for treating active psoriatic arthritis	TA340	4 June 2015	3 March 2017
Ustekinumab for the treatment of adults with moderate to severe psoriasis	TA180	23 September 2009	3 March 2017
Everolimus for advanced renal cell carcinoma after previous treatment	TA432	22 February 2017	22 February 2017
Apremilast for treating active psoriatic arthritis	TA433	22 February 2017	22 February 2017
Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation	TA429	25 January 2017	25 January 2017
Sofosbuvir–velpatasvir for treating chronic hepatitis C	TA430	25 January 2017	25 January 2017
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib	TA427	11 January 2017	11 January 2017
Everolimus with exemestane for treating advanced breast cancer after endocrine therapy	TA421	21 December 2016	21 December 2016
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA422	21 December 2016	21 December 2016
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens	TA423	21 December 2016	21 December 2016